Tag

HKG: 9926

Summit Therapeutics reports 25% lower death risk in biliary-cancer trial
Adrian Kessler · Oct 25, 2026
Summit Therapeutics agrees to US$2B AstraZeneca equity investment
Adrian Kessler · Sep 29, 2026